Literature DB >> 15735761

Tweak induces mammary epithelial branching morphogenesis.

Jennifer S Michaelson1, Sandy Cho, Beth Browning, Timothy S Zheng, John M Lincecum, Monica Z Wang, Yen-Ming Hsu, Linda C Burkly.   

Abstract

Members of the tumor necrosis factor (TNF) superfamily regulate cell survival and proliferation and have been implicated in cancer. Tweak (TNF-related weak inducer of apoptosis) has pleiotropic biological functions including proapoptotic, proangiogenic and proinflammatory activities. We explored a role for Tweak in mammary gland transformation using a three-dimensional model culture system. Tweak stimulates a branching morphogenic phenotype, similar to that induced by pro-oncogenic factors, in Eph4 mammary epithelial cells cultured in matrigel. Increased proliferation and invasiveness are observed, with a concomitant inhibition of functional differentiation. Levels of matrix metalloproteinase-9 (MMP-9) are significantly increased following Tweak treatment. Notably, MMP inhibitors are sufficient to block the branching phenotype induced by Tweak. The capacity to promote proliferation, inhibit differentiation and induce invasion suggests a role for Tweak in mammary gland tumorigenesis. Consistent with this, we have observed elevated protein levels of the Tweak receptor, Fn14, in human breast tumor cell lines and xenograft models as well as in primary human breast tumors. Together, our results suggest that the Tweak/Fn14 pathway may be protumorigenic in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735761     DOI: 10.1038/sj.onc.1208208

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer.

Authors:  Celeste M Nelson; Mina J Bissell
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

2.  Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.

Authors:  Sujatha Gurunathan; Jeffrey A Winkles; Sankar Ghosh; Matthew S Hayden
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

3.  Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.

Authors:  Hong Zhou; Khalid A Mohamedali; Ana Maria Gonzalez-Angulo; Yu Cao; Mary Migliorini; Lawrence H Cheung; Janine LoBello; Xiudong Lei; Yuan Qi; Walter N Hittelman; Jeffrey A Winkles; Nhan L Tran; Michael G Rosenblum
Journal:  Mol Cancer Ther       Date:  2014-09-19       Impact factor: 6.261

4.  cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and Tumorigenesis.

Authors:  David Carr; Rosanna Lau; Alexandra D Hnatykiw; Gwendoline C D Ward; Manijeh Daneshmand; Miguel A Cabrita; M A Christine Pratt
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-06-06       Impact factor: 2.673

5.  Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.

Authors:  Timothy G Whitsett; Emily Cheng; Landon Inge; Kaushal Asrani; Nathan M Jameson; Galen Hostetter; Glen J Weiss; Christopher B Kingsley; Joseph C Loftus; Ross Bremner; Nhan L Tran; Jeffrey A Winkles
Journal:  Am J Pathol       Date:  2012-05-23       Impact factor: 4.307

6.  Transient TWEAK overexpression leads to a general salivary epithelial cell proliferation.

Authors:  T Sugito; F Mineshiba; C Zheng; A P Cotrim; C M Goldsmith; B J Baum
Journal:  Oral Dis       Date:  2008-09-29       Impact factor: 3.511

7.  The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.

Authors:  Kaushal Asrani; Ruth A Keri; Rebeca Galisteo; Sharron A N Brown; Sarah J Morgan; Arundhati Ghosh; Nhan L Tran; Jeffrey A Winkles
Journal:  Mol Cancer Res       Date:  2013-02-01       Impact factor: 5.852

Review 8.  TWEAK and the central nervous system.

Authors:  Manuel Yepes
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 9.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

10.  The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity.

Authors:  Amanda L Willis; Nhan L Tran; Julie M Chatigny; Nichole Charlton; Hong Vu; Sharron A N Brown; Michael A Black; Wendy S McDonough; Shannon P Fortin; Joshua R Niska; Jeffrey A Winkles; Heather E Cunliffe
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.